» Articles » PMID: 31988391

B Cells, Plasma Cells and Antibody Repertoires in the Tumour Microenvironment

Overview
Journal Nat Rev Immunol
Date 2020 Jan 29
PMID 31988391
Citations 308
Authors
Affiliations
Soon will be listed here.
Abstract

Recent data show that B cells and plasma cells located in tumours or in tumour-draining lymph nodes can have important roles in shaping antitumour immune responses. In tumour-associated tertiary lymphoid structures, T cells and B cells interact and undergo cooperative selection, specialization and clonal expansion. Importantly, B cells can present cognate tumour-derived antigens to T cells, with the functional consequences of such interactions being shaped by the B cell phenotype. Furthermore, the isotype and specificity of the antibodies produced by plasma cells can drive distinct immune responses. Here we summarize our current knowledge of the roles of B cells and antibodies in the tumour microenvironment. Moreover, we discuss the potential of using immunoglobulin repertoires as a source of tumour-specific receptors for immunotherapy or as biomarkers to predict the efficacy of immunotherapeutic interventions.

Citing Articles

Tumor-infiltrating B cells in non-small cell lung cancer: current insights and future directions.

Jiang S, Zhu D, Wang Y Cancer Cell Int. 2025; 25(1):68.

PMID: 40011889 PMC: 11866835. DOI: 10.1186/s12935-025-03668-3.


Harnessing TAGAP to improve immunotherapy for lung squamous carcinoma treatment by targeting c-Rel in CD4+ T cells.

Cai P, Sun H, Jiang T, Li H, Huang D, Hao X Cancer Immunol Immunother. 2025; 74(4):114.

PMID: 39998561 PMC: 11861500. DOI: 10.1007/s00262-025-03960-1.


POU2F2 B cells enhance antitumor immunity and predict better survival in non small cell lung cancer.

Shi H, Wang W, Luo J, Song G, Han R Sci Rep. 2025; 15(1):6549.

PMID: 39994401 PMC: 11850725. DOI: 10.1038/s41598-025-90817-3.


B cell immunometabolism in health and disease.

Martinis E, Tonon S, Colamatteo A, La Cava A, Matarese G, Pucillo C Nat Immunol. 2025; 26(3):366-377.

PMID: 39984733 DOI: 10.1038/s41590-025-02102-0.


MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation.

Armstrong D, Chang C, Hong M, Green L, Shen Y, Hudson W Sci Adv. 2025; 11(7):eads4227.

PMID: 39937892 PMC: 11817953. DOI: 10.1126/sciadv.ads4227.


References
1.
Schumacher T, Schreiber R . Neoantigens in cancer immunotherapy. Science. 2015; 348(6230):69-74. DOI: 10.1126/science.aaa4971. View

2.
Wherry E, Kurachi M . Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015; 15(8):486-99. PMC: 4889009. DOI: 10.1038/nri3862. View

3.
Wei S, Levine J, Cogdill A, Zhao Y, Anang N, Andrews M . Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell. 2017; 170(6):1120-1133.e17. PMC: 5591072. DOI: 10.1016/j.cell.2017.07.024. View

4.
Borst J, Ahrends T, Babala N, Melief C, Kastenmuller W . CD4 T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018; 18(10):635-647. DOI: 10.1038/s41577-018-0044-0. View

5.
Schoorl R, Riviere A, Borne A, Feltkamp-Vroom T . Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques. Am J Pathol. 1976; 84(3):529-44. PMC: 2032535. View